Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study.

Van Loon E, Gazut S, Yazdani S, Lerut E, de Loor H, Coemans M, Noël LH, Thorrez L, Van Lommel L, Schuit F, Sprangers B, Kuypers D, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

EBioMedicine. 2019 Jul 26. pii: S2352-3964(19)30463-3. doi: 10.1016/j.ebiom.2019.07.028. [Epub ahead of print]

2.

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Gérardin C, Moktefi A, Couchoud C, Duquesne A, Ouali N, Gataut P, Karras A, Anglicheau D, Lefaucheur C, Figueres L, Albano L, Lionet A, Novion M, Ziliotis MJ, Louis M, Del Bello A, Matignon M, Dahan K, Habibi A, Galacteros F, Bartolucci P, Grimbert P, Audard V.

Br J Haematol. 2019 Jul 26. doi: 10.1111/bjh.16113. [Epub ahead of print]

PMID:
31348518
3.

Osmoregulation Performance and Kidney Transplant Outcome.

Mazloum M, Jouffroy J, Brazier F, Legendre C, Neuraz A, Garcelon N, Prié D, Anglicheau D, Bienaimé F.

J Am Soc Nephrol. 2019 Jul;30(7):1282-1293. doi: 10.1681/ASN.2018121269. Epub 2019 Jun 19.

PMID:
31217325
4.

Temporal virus serological profiling of kidney graft recipients using VirScan.

Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10899-10904. doi: 10.1073/pnas.1821166116. Epub 2019 May 13.

PMID:
31085644
5.

Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox.

Jackson AM, Delville M, Lamarthée B, Anglicheau D.

Hum Immunol. 2019 May 1. pii: S0198-8859(19)30195-8. doi: 10.1016/j.humimm.2019.04.014. [Epub ahead of print] Review.

PMID:
31054781
6.

WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint].

Anglicheau D, Delville M, Lamarthee B.

Nephrol Ther. 2019 Apr;15 Suppl 1:S53-S59. doi: 10.1016/j.nephro.2019.03.003. French.

PMID:
30981396
7.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
8.

Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approach.

Châtelet V, Gatault P, Hazzan M, Anglicheau D, Launoy G, Lobbedez T, Moulin B.

Transpl Int. 2019 Aug;32(8):865-875. doi: 10.1111/tri.13429. Epub 2019 Apr 2.

PMID:
30903630
9.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
10.

Conversion from calcineurin inhibitors to belatacept in HLA- sensitized kidney-transplant recipients with low-level donor specific antibodies.

Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.

Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002592. [Epub ahead of print]

PMID:
30720681
11.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Jan 3. doi: 10.1093/ndt/gfy386. [Epub ahead of print]

PMID:
30608553
12.

No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.

Devresse A, Tinel C, Vermorel A, Snanoudj R, Morin L, Avettand-Fenoel V, Amrouche L, Scemla A, Zuber J, Legendre C, Rabant M, Anglicheau D.

Transpl Int. 2019 May;32(5):481-492. doi: 10.1111/tri.13392. Epub 2019 Jan 11.

PMID:
30565748
13.

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.

Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3.

14.

[Human resources allocated to kidney transplantation in 2016 in France: A national survey].

Gatault P, Hazzan M, Anglicheau D, Moulin B; Commission transplantation de la SFNDT.

Nephrol Ther. 2018 Nov;14(6):491-498. doi: 10.1016/j.nephro.2018.06.002. Epub 2018 Aug 25. French.

PMID:
30154055
15.

Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.

Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M.

Kidney Int. 2018 Nov;94(5):964-973. doi: 10.1016/j.kint.2018.05.018. Epub 2018 Jul 24.

PMID:
30049474
16.

No impact of disseminated intravascular coagulation in kidney donors on long-term kidney transplantation outcome: A multicenter propensity-matched study.

Garrouste C, Baudenon J, Gatault P, Pereira B, Etienne I, Thierry A, Szlavik N, Aniort J, Rabant M, Lambert C, Sayegh J, Oniszczuk J, Anglicheau D, Heng AE.

Am J Transplant. 2019 Feb;19(2):448-456. doi: 10.1111/ajt.15008. Epub 2018 Aug 23.

PMID:
29981217
17.

The 1-year Renal Biopsy Index: a scoring system to drive biopsy indication at 1-year post-kidney transplantation.

Giral M, Renaudin K, Naesens M, Luning R, Anglicheau D, Morelon E, Huneau A, Paul C, Brouard S, Couvrat-Desvergnes G, Foucher Y, Dantan E.

Transpl Int. 2018 Jun 12. doi: 10.1111/tri.13290. [Epub ahead of print] Review.

18.

Urinary transcriptomics reveals patterns associated with subclinical injury of the renal allograft.

Galichon P, Xu-Dubois YC, Buob D, Tinel C, Anglicheau D, Benbouzid S, Dahan K, Ouali N, Hertig A, Brocheriou I, Rondeau E.

Biomark Med. 2018 May;12(5):427-438. doi: 10.2217/bmm-2017-0330. Epub 2018 Apr 26.

PMID:
29697267
19.

A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen.

Woillard JB, Gatault P, Picard N, Arnion H, Anglicheau D, Marquet P.

Am J Transplant. 2018 Dec;18(12):2905-2913. doi: 10.1111/ajt.14894. Epub 2018 Jun 1.

PMID:
29689130
20.

Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival.

See SB, Aubert O, Loupy A, Veras Y, Lebreton X, Gao B, Legendre C, Anglicheau D, Zorn E.

J Am Soc Nephrol. 2018 Jun;29(6):1761-1770. doi: 10.1681/ASN.2017111157. Epub 2018 Mar 30.

21.

Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus.

Devresse A, Leruez-Ville M, Scemla A, Avettand-Fenoel V, Morin L, Lebreton X, Tinel C, Amrouche L, Lamhaut L, Timsit MO, Zuber J, Legendre C, Anglicheau D.

Transpl Infect Dis. 2018 Apr;20(2):e12846. doi: 10.1111/tid.12846. Epub 2018 Feb 21.

PMID:
29360195
22.

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.

Bienaimé F, Dechartres A, Anglicheau D, Sabbah L, Montgermont P, Friedlander G, Ravaud P, Legendre C, Prié D.

Kidney Int Rep. 2017 May 18;2(5):881-892. doi: 10.1016/j.ekir.2017.05.007. eCollection 2017 Sep.

23.

Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.

Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S.

Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009.

PMID:
29215458
24.

Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.

Rabant M, Boullenger F, Gnemmi V, Pellé G, Glowacki F, Hertig A, Brocheriou I, Suberbielle C, Taupin JL, Anglicheau D, Legendre C, Duong Van Huyen JP, Buob D.

Am J Transplant. 2018 Apr;18(4):972-981. doi: 10.1111/ajt.14617. Epub 2018 Jan 12.

25.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
26.

Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review.

Rouzaud C, Chosidow O, Brocard A, Fraitag S, Scemla A, Anglicheau D, Bouaziz JD, Dupin N, Bougnoux ME, Hay R, Lortholary O, Lanternier F; French Mycoses Study Group.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12799. Epub 2018 Jan 25.

PMID:
29094463
27.

Precision Transplant Medicine: Biomarkers to the Rescue.

Naesens M, Anglicheau D.

J Am Soc Nephrol. 2018 Jan;29(1):24-34. doi: 10.1681/ASN.2017010004. Epub 2017 Oct 9. Review.

28.

A Comparative Study of the Predictive Values of Urinary Acute Kidney Injury Markers Angiogenin and Kidney Injury Molecule 1 for the Outcomes of Kidney Allografts.

Tavernier Q, Tinel C, Rabant M, Morin L, Anglicheau D, Pallet N.

Transplant Direct. 2017 Aug 16;3(9):e204. doi: 10.1097/TXD.0000000000000720. eCollection 2017 Sep.

29.

Lung cancer in renal transplant recipients: A case-control study.

Rousseau-Gazaniol C, Fraboulet S, Couderc LJ, Kreis H, Borie R, Tricot L, Anglicheau D, Martinez F, Doubre H, Bonnette P, Mellot F, Massiani MA, Pelle G, Sage E, Moisson P, Delahousse M, Zemoura L, Chapelier A, Hamid AM, Puyo P, Longchampt E, Legendre C, Friard S, Catherinot E.

Lung Cancer. 2017 Sep;111:96-100. doi: 10.1016/j.lungcan.2017.07.011. Epub 2017 Jul 11.

PMID:
28838407
30.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

31.

Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.

Deltombe C, Gillaizeau F, Anglicheau D, Morelon E, Trébern-Launay K, Le Borgne F, Rimbert M, Guérif P, Malard-Castagnet S, Foucher Y, Giral M.

Transpl Int. 2017 Nov;30(11):1150-1160. doi: 10.1111/tri.13009. Epub 2017 Oct 5.

32.

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.

Amrouche L, Aubert O, Suberbielle C, Rabant M, Van Huyen JD, Martinez F, Sberro-Soussan R, Scemla A, Tinel C, Snanoudj R, Zuber J, Cavalcanti R, Timsit MO, Lamhaut L, Anglicheau D, Loupy A, Legendre C.

Transplantation. 2017 Oct;101(10):2440-2448. doi: 10.1097/TP.0000000000001650.

PMID:
28114171
33.

Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.

Flahault A, Anglicheau D, Loriot MA, Thervet E, Pallet N.

Pharmacogenomics. 2017 Jan;18(2):165-173. doi: 10.2217/pgs-2016-0146. Epub 2016 Dec 15.

PMID:
27977332
34.

Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.

Luque Y, Anglicheau D, Rabant M, El Karoui K, Jamme M, Aubert O, Clément R, Noël LH, Bollée G, Brodin-Sartorius A, Martinie M, Kreis H, Timsit MO, Legendre C.

Transpl Int. 2016 Nov;29(11):1205-1215. doi: 10.1111/tri.12833. Epub 2016 Sep 9.

35.

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.

36.

Ultrasound-based imaging methods of the kidney-recent developments.

Correas JM, Anglicheau D, Joly D, Gennisson JL, Tanter M, Hélénon O.

Kidney Int. 2016 Dec;90(6):1199-1210. doi: 10.1016/j.kint.2016.06.042. Epub 2016 Sep 21. Review.

PMID:
27665116
37.

Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.

Damon C, Luck M, Toullec L, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Thierry A, Vigneau C, Moulin B, Heng AE, Subra JF, Legendre C, Monnot A, Yartseva A, Bateson M, Laurent-Puig P, Anglicheau D, Beaune P, Loriot MA, Thervet E, Pallet N.

Am J Transplant. 2017 Apr;17(4):1008-1019. doi: 10.1111/ajt.14040. Epub 2016 Oct 7.

38.

Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches.

Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P.

Transplantation. 2016 Oct;100(10):2024-38. doi: 10.1097/TP.0000000000001321. Review.

PMID:
27479159
39.

MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of Action.

Amrouche L, Desbuissons G, Rabant M, Sauvaget V, Nguyen C, Benon A, Barre P, Rabaté C, Lebreton X, Gallazzini M, Legendre C, Terzi F, Anglicheau D.

J Am Soc Nephrol. 2017 Feb;28(2):479-493. doi: 10.1681/ASN.2016010045. Epub 2016 Jul 21.

40.

Urinary Angiogenin Reflects the Magnitude of Kidney Injury at the Infrahistologic Level.

Tavernier Q, Mami I, Rabant M, Karras A, Laurent-Puig P, Chevet E, Thervet E, Anglicheau D, Pallet N.

J Am Soc Nephrol. 2017 Feb;28(2):678-690. doi: 10.1681/ASN.2016020218. Epub 2016 Jul 19.

41.

Genome-Wide Association Study of Acute Renal Graft Rejection.

Ghisdal L, Baron C, Lebranchu Y, Viklický O, Konarikova A, Naesens M, Kuypers D, Dinic M, Alamartine E, Touchard G, Antoine T, Essig M, Rerolle JP, Merville P, Taupin JL, Le Meur Y, Grall-Jezequel A, Glowacki F, Noël C, Legendre C, Anglicheau D, Broeders N, Coppieters W, Docampo E, Georges M, Ajarchouh Z, Massart A, Racapé J, Abramowicz D, Abramowicz M.

Am J Transplant. 2017 Jan;17(1):201-209. doi: 10.1111/ajt.13912. Epub 2016 Jul 22.

42.

Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?

Delville M, Charreau B, Rabant M, Legendre C, Anglicheau D.

Hum Immunol. 2016 Nov;77(11):1055-1062. doi: 10.1016/j.humimm.2016.05.021. Epub 2016 May 26. Review.

PMID:
27237040
43.

Urinary mRNA for the Diagnosis of Renal Allograft Rejection: The Issue of Normalization.

Galichon P, Amrouche L, Hertig A, Brocheriou I, Rabant M, Xu-Dubois YC, Ouali N, Dahan K, Morin L, Terzi F, Rondeau E, Anglicheau D.

Am J Transplant. 2016 Oct;16(10):3033-3040. doi: 10.1111/ajt.13891. Epub 2016 Jul 8.

44.

Stat3 Controls Tubulointerstitial Communication during CKD.

Bienaimé F, Muorah M, Yammine L, Burtin M, Nguyen C, Baron W, Garbay S, Viau A, Broueilh M, Blanc T, Peters D, Poli V, Anglicheau D, Friedlander G, Pontoglio M, Gallazzini M, Terzi F.

J Am Soc Nephrol. 2016 Dec;27(12):3690-3705. Epub 2016 May 6.

45.

Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.

Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.

Transplantation. 2017 Mar;101(3):649-656. doi: 10.1097/TP.0000000000001160.

PMID:
27043407
46.

[Renal elastography].

Correas JM, Anglicheau D, Gennisson JL, Tanter M.

Nephrol Ther. 2016 Apr;12 Suppl 1:S25-34. doi: 10.1016/j.nephro.2016.02.014. Epub 2016 Mar 11. French.

PMID:
26976058
47.

A Novel Extrinsic Pathway for the Unfolded Protein Response in the Kidney.

Mami I, Tavernier Q, Bouvier N, Aboukamis R, Desbuissons G, Rabant M, Poindessous V, Laurent-Puig P, Beaune P, Tharaux PL, Thervet E, Chevet E, Anglicheau D, Pallet N.

J Am Soc Nephrol. 2016 Sep;27(9):2670-83. doi: 10.1681/ASN.2015060703. Epub 2016 Jan 28.

48.

Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients.

Rabant M, Amrouche L, Morin L, Bonifay R, Lebreton X, Aouni L, Benon A, Sauvaget V, Le Vaillant L, Aulagnon F, Sberro R, Snanoudj R, Mejean A, Legendre C, Terzi F, Anglicheau D.

Am J Transplant. 2016 Jun;16(6):1868-81. doi: 10.1111/ajt.13677. Epub 2016 Mar 10.

49.

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.

Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, Rivalan J, Thervet E, Essig M, Babinet F, Subra JF, Toubas O, Rieu P, Launois C, Perotin-Collard JM, Lebargy F, Deslée G; Spiesser group.

BMC Pulm Med. 2015 Nov 7;15:141. doi: 10.1186/s12890-015-0133-9.

50.

Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.

Luque Y, Jamme M, Rabant M, DeWolf S, Noël LH, Thervet E, Chatenoud L, Snanoudj R, Anglicheau D, Legendre C, Candon S, Zuber J.

Nephrol Dial Transplant. 2016 Mar;31(3):487-95. doi: 10.1093/ndt/gfv362. Epub 2015 Oct 22.

PMID:
26492923

Supplemental Content

Loading ...
Support Center